|
|
California Cancer Registry Volume I: Data Standards and Data Dictionary Source: Cancer Reporting in California: Abstracting and Coding Procedures for Hospitals (California Cancer Reporting System Standards, Vol. I), updated May 2007 |
|
|
|
|
|
California Cancer Registry Volume I: Data Standards and Data Dictionary Source: Cancer Reporting in California: Abstracting and Coding Procedures for Hospitals (California Cancer Reporting System Standards, Vol. I), updated May 2007 |
|
|
|
Prepare a single abstract for certain combinations of ductal and lobular carcinomas occurring in the same breast within two months of each other (see Section V.1 for coding the primary site). ICD-O-2 has assigned morphology 8522 to this combination. Code as follows:
Infiltrating duct carcinoma (8500/3) and lobular carcinoma (8520/3) --code 8522/3.
Infiltrating duct carcinoma (8500/3) and lobular carcinoma in situ (8520/2) --code 8522/3.
Intraductal carcinoma (8500/2) and lobular carcinoma (8520/3) --code 8522/3.
Intraductal carcinoma (8500/2) and lobular carcinoma in situ (8520/2) --code 8522/2.
Infiltrating duct mixed with other types of carcinoma (i.e. - duct and cribriform, mucinous, tubular or colloid carcinoma) --code 8523/3.
Infiltrating lobular mixed with other types of carcinoma --code 8524/3.
Prepare separate abstracts for a ductal lesion in one breast and a lobular lesion in the other breast, whether or not they occur within two months of each other.
Enter code 8543/3 for a combination of intraductal carcinoma (8500/2) and Paget's Disease (8540/3).
SEER Program Manual entry available
